Metastatic carcinoma
Conditions
Interventions
Sponsors
Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Patients older than 18 years old, male and female unlimited; 2. The primary metastatic carcinoma could be confirmed by pathological biopsy; 3. Patients with complete clinical and prognostic information; 4. The subjects and their family members were able to understand the study protocol and were willing to participate in the study and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with inflammatory reaction caused by acute and severe diseases in recent period (14 days before blood drawing); or hormone therapy was used in 14 days before blood drawing; 2. Patients with a history of other tumor diseases or with other genetic diseases; 3. Patients who have received organ transplantation, stem cell transplantation, bone marrow transplantation or blood transfusion in recent one month; 4. Pregnant women; 5. Patients who are participating in other clinical trials (including bowel preparation, anesthesia, etc.) who need to take drugs in the past 60 days; 6. Patients with severe cardiovascular disease, uncontrolled infection, or other uncontrollable comorbidities; 7. Patients or family members could not understand the conditions and objectives of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum circulating microRNA;consistency;Accurary; | — |
Countries
China
Contacts
Public ContactYiyin Chen
Xuzhou Medical University
Outcome results
None listed